GW Pharmaceuticals PLC GWPH:NASDAQ

Last Price$138.37Cboe Real-Time Last Sale as of 9:50AM ET 9/18/19
Cboe Real-Time Quotes
Realtime quote and/or trade prices are not sourced from all markets
Today's Change+0.73(0.53%)
Bid (Size)$137.78 (100)
Ask (Size)$138.25 (5)
Day Low / High$137.14 - 138.42
Volume11.8 K
 

View Pharmaceuticals: Other IndustryPeer Comparison as of 09/18/2019

 

GW Pharmaceuticals PLC ( NASDAQ )

Price: $138.37
Change: +0.73 (0.53%)
Volume: 11.8 K
9:50AM ET 9/18/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

European ADRs Edge Higher in Wednesday Trading
10:59AM ET 9/11/2019 MT Newswires

American depositary receipts of European stocks were trading 0.14% higher at 1,013.77 on the BNY Mellon Europe Select ADR Index on Wednesday. In...

ADR Top % Movers in Pre-Market Trading
6:24AM ET 9/05/2019 MT Newswires

ADR Top % Movers in Pre-Market Trading Gainers STM +4.0% NOK +2.0% BP +1.1% SAN +0.8% RDS-B +0.8% RDS-A +0.6% GWPH +0.6% Losers TEVA -3.8% BBL -3.1% GSK...

European ADRs Move Higher in Wednesday Trading
10:32AM ET 9/04/2019 MT Newswires

American Depositary Receipts of European stocks were trading 0.95% higher at 1,000.45 on the BNY Mellon Europe Select ADR Index on Wednesday. In...

2019, 2020 Earnings Estimates for GW Pharmaceuticals Lowered
8:21AM ET 9/04/2019 MT Newswires

GW Pharmaceuticals Plc's (NASDAQ:GWPH, Recent Price: 142.94) full year forecasted earnings estimates for 2019 and 2020 have been lowered. The consensus for...

View all Commentary and Analysis

GW Pharmaceuticals (GWPH) Investor Presentation - Slideshow
1:53PM ET 9/16/2019 Seeking Alpha

The Zacks Analyst Blog Highlights: Anheuser-Busch, Fly Leasing, GW Pharmaceuticals, Nestl?? and Burberry
9:14AM ET 9/16/2019 Zacks

The Zacks Analyst Blog Highlights: Anheuser-Busch, Fly Leasing, GW Pharmaceuticals, Nestl?? and...

The Changing Cannabis Narrative With Debra Borchardt
6:30AM ET 9/11/2019 Seeking Alpha

GW Pharmaceuticals Facing Some Problems In Europe
2:12PM ET 9/03/2019 Seeking Alpha

Company Profile

Business DescriptionGW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics. It offers its lead cannabinoid product, Epidiolex oral solution CV, a pharmaceutical formulation of cannabidiol (CBD) focusing on the treatment of seizures associated with tuberous sclerosis complex. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. View company web site for more details
AddressSovereign House
Cambridge, Cambridgeshire CB24 9BZ
Phone+44.1223.266800
Number of Employees801
Recent SEC Filing08/21/20194
Chief Executive Officer & Executive DirectorJustin D. Gover
Chief Operating OfficerChristopher John Tovey
CFO & Principal Accounting OfficerScott M. Giacobello
Chief Medical OfficerVolker Knappertz

Company Highlights

Price Open$136.45
Previous Close$137.64
52 Week Range$90.14 - 196.00
Market Capitalization$4.3 B
Shares Outstanding30.9 M
SectorHealth Technology
IndustryPharmaceuticals: Other
Next Earnings Announcement11/26/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$6.87
Beta vs. S&P 500N/A
Revenue$15.5 M
Net Profit Margin-232.32%
Return on Equity-21.37%

Analyst Ratings as of 05/07/2019

Buy
13
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset